or
forgot password
  • cancer clinical trials in salt lake city, UT

  • Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
    University of Utah / Huntsman Cancer Institute Huntsman
    Salt Lake City, Utah 84103
    Advanced Solid Tumors, Excluding Breast Cancer
    Patient Reported Symptoms in Ovarian Cancer (PRECISION)

    Salt Lake City, Utah 84112
    Ovarian Cancer
    Safety Study Evaluating Twice-Daily Administration of CYT387 in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis
    Huntsman Cancer Institute at the University of Utah
    Salt Lake City, Utah 84112
    Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis
    A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
    University of Utah / Huntsman Cancer Institute Huntsman (3)
    Salt Lake City, Utah 84103
    Advanced and Selected Solid Tumors
    A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers

    Salt Lake City, Utah 84112
    Colorectal Cancer, Squamous Cell Head and Neck Cancer, Non-small Cell Lung Cancer, Triple Negative Breast Cancer, Other Tumors With EGFR Dependence
    Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
    University of Utah
    Salt Lake City, Utah
    Nonhematologic Malignancies, Lymphoma
    Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
    Acceleron Investigative Site
    Salt Lake City, Utah
    Squamous Cell Carcinoma of the Head and Neck
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    Local Institution
    Salt Lake City, Utah
    Leukemia, Pediatric
    Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
    Primary Children's Medical Center
    Salt Lake City, Utah 84113-1100
    Childhood Cerebral Astrocytoma/Malignant Glioma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma, Childhood Mixed Glioma, Childhood Oligodendroglioma, Childhood Supratentorial Ependymoma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma
    Use of Multiple Brain Imaging Modalities (PET and MRS) to Identify Metabolic Abnormalities in Major Depression
    University of Utah Dept of Psychiatry
    Salt Lake City, Utah 84112
    Major Depressive Disorder
    A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
    University of Utah HSC
    Salt Lake City, Utah 84132
    Crohn's Disease
    Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
    Wasatch Clinical Research

    Trial Locations
    Wasatch Clinical Research
    Wasatch Endoscopy Center
    Alpine Medical Group
    Ulcerative Colitis
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Utah Cancer Specialists
    Salt Lake City, Utah 84106
    Colorectal Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    University of Utah Department of Neurosurgery
    Salt Lake City, Utah 84112
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients
    University of Utah / Huntsman Cancer Institute Huntsman UT
    Salt Lake City, Utah 84103
    Pancreatic Cancer
    Phase 3 Papulopustular Rosacea Study
    Dermatology Research Center, Inc.
    Salt Lake City, Utah 84124
    Papulopustular Rosacea (PPR)
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    University of Utah Hospital
    Salt Lake City, Utah 84113
    ST Segment Elevation Myocardial Infarction
    Dose-Escalation and Safety Trial of YN968D1
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Cancer Patients With Solid Tumors
    A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
    Utah Cancer Specialists
    Salt Lake City, Utah 84106
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component, Recurrent Glioblastoma, Relapsed Glioblastoma
    Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
    Investigational Site Number 840004
    Salt Lake City, Utah 84112-5550
    Small Cell Lung Cancer
    Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
    University of Utah
    Salt Lake City, Utah
    Lambert-Eaton Myasthenic Syndrome, Eaton-Lambert Myasthenic Syndrome
    Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
    LDS Hospital

    Trial Locations
    LDS Hospital
    Utah Cancer Specialists at UCS Cancer Center
    Huntsman Cancer Institute at University of Utah
    Colorectal Cancer
    Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
    GSK Investigational Site
    Salt Lake City, Utah 84107
    Leukaemia, Lymphocytic, Chronic
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Huntsman Cancer Institute/University of Utah
    Salt Lake City, Utah 84112
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
    Investigational Site Number 840015
    Salt Lake City, Utah 84112-5550
    Hematopoietic Neoplasm
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Huntsman Cancer Institute/University of Utah
    Salt Lake City, Utah 84112
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
    Dermatology Research Center, Inc.
    Salt Lake City, Utah 84124
    Actinic Keratosis
    Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
    The Huntsman Cancer Institute, University of Utah
    Salt Lake City, Utah 84112-5550
    Melanoma
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    LDS Hospital

    Trial Locations
    LDS Hospital
    Huntsman Cancer Institute/University of Utah
    Utah Cancer Specialists-Salt Lake City
    Breast Cancer
    A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors
    University of Utah / Huntsman Cancer Institute Huntsman
    Salt Lake City, Utah 84103
    KRAS Mutated Colorectal Adenocarcinoma., Metastatic Pancreatic Adenocarcinoma, BRAF Mutated Melanoma
    A Multi-Center Trial of the ProLung Test™
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Solitary Pulmonary Nodule, Multiple Pulmonary Nodules
    Phase 3 Study With Carfilzomib and Dexamethasone Versus Velcade and Dexamethasone for Relapsed Multiple Myeloma Patients
    Huntsman Cancer Institute

    Trial Locations
    Huntsman Cancer Institute
    University of Utah School of Medicine
    Multiple Myeloma
    Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
    University of Utah / Huntsman Cancer Institute Huntsman
    Salt Lake City, Utah 84103
    Dose Escalation, Safety, Preliminary Efficacy, Advanced Solid Tumors, Metastatic Breast Cancer, Advanced Pancreatic Adenocarcinoma, Metastatic Colorectal Cancer, Recurrent Glioblastoma Multiforme
    Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Recurrent Glioma
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    University of Utah
    Salt Lake City, Utah
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
    Primary Children's Hospital
    Salt Lake City, Utah 84113
    Neuroblastoma in Remission
    Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
    Huntsman Cancer Institute At The Univ. Of Utah
    Salt Lake City, Utah 84112
    Non-Hodgkin's Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Chronic Myelogenous Leukemia
    A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer
    University of Utah / Huntsman Cancer Institute Huntsman
    Salt Lake City, Utah 84103
    HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Radiant Research

    Trial Locations
    Radiant Research
    Phase II Sexual Medicine and Menopause
    Obesity, Overweight
    Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
    University of Utah
    Salt Lake City, Utah
    Cytomegalovirus Infections
    Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Patients at Risk for Melanoma
    Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance
    Huntsman Cancer Institute
    Salt Lake City, Utah 84112
    Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
    Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer
    For information concerning this clinical site, please contact Nymox at 800-936-9669.
    Salt Lake City, Utah 84124
    Prostate Cancer